And while it is impossible to predict all the surprises that the legislature may be preparing for us, it is already possible to list several important changes in the law, the likelihood of which seems to be particularly high in the coming months.
Pharmaceutical prescriptions and free drugs for seniors and children
The first major legislative process for the medical and pharmaceutical market this year is almost complete: the Act of December 5, 2024, amending the Act on health care services financed from public funds and certain other acts is now only awaiting the President's signature and publication. If the law is signed and published in the Journal of Laws, then it will enter into force within 14 days from the date of promulgation; this could happen as early as in the coming weeks.
This law is very important, first and foremost, for patients, as it introduces regulatory changes that should translate into increased access to medicines. These include changes to the prescribing rules for reimbursed drugs entitled free of charge to seniors and children, as well as to pharmaceutical prescriptions for vaccines. According to the amendment, patients over 65 or under 18 years of age will be entitled to free supply of selected reimbursed drugs on the basis of a prescription issued by an "authorized person" within the meaning of the Reimbursement Law; and not, as before, by a doctor or a nurse at the POZ. "Eligible person," as referred to in the provision amended by the amendment, is a person with the right to practice a medical profession who, under the regulations governing the practice of the medical profession in question, is authorized to issue prescriptions.
The second major change introduced by the December 5, 2024 law is an amendment to Article 96, paragraph 41 of the Pharmaceutical Law. It moves to allow pharmaceutical prescriptions to ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].